BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. May 27, 2026; 18(5): 115921
Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.115921
Table 1 Comparison of baseline data between two groups, n (%)
Item
Study group (n = 60)
Control group (n = 60)
t/χ2
P value
Age (years, mean ± SD)58.4 ± 12.360.1 ± 11.7-0.7860.434
Gender0.2670.605
    Male36 (60.0)39 (65.0)
    Female24 (40.0)21 (35.0)
BMI (kg/m², mean ± SD)22.1 ± 3.421.8 ± 3.20.5120.610
Gastric cancer pathological type1.4290.699
    Adenocarcinoma48 (80.0)51 (85.0)
    Signet ring cell carcinoma8 (13.3)6 (10.0)
    Others4 (6.7)3 (5.0)
Surgical method0.6980.705
    Total gastrectomy15 (25.0)18 (30.0)
    Distal subtotal gastrectomy32 (53.3)29 (48.3)
    Proximal subtotal gastrectomy13 (21.7)13 (21.7)
Postoperative time (months, mean ± SD)3.2 ± 1.83.5 ± 2.1-0.8460.399
Past medical history
    Hypertension18 (30.0)22 (36.7)0.6160.433
    Diabetes8 (13.3)11 (18.3)0.5710.450
    Coronary heart disease5 (8.3)7 (11.7)0.3800.537
    Comorbid conditions
    Gastroesophageal reflux disease12 (20.0)15 (25.0)0.4370.509
Chronic gastritis8 (13.3)10 (16.7)0.2670.605
    Irritable bowel syndrome4 (6.7)6 (10.0)0.4340.510
Preoperative gastroscopy results0.8470.838
    Gastric antrum lesions28 (46.7)31 (51.7)
    Gastric body lesions18 (30.0)16 (26.7)
    Gastric fundus lesions9 (15.0)8 (13.3)
    Diffuse lesions5 (8.3)5 (8.3)


Write to the Help Desk